Cheyne Capital Management (UK) LLP / RARE
Cheyne Capital Management (UK) LLP’s Ultragenyx Pharmaceutical In Position
Does Cheyne Capital Management (UK) LLP own Ultragenyx Pharmaceutical In (RARE)? Not currently — the last reported position was 17.1K shares worth $792,938 in Q4 2022; the fund’s latest 13F (Q4 2023) no longer reports it.
Position Value
$792,938
Q4 2022
Shares
17.1K
% of Portfolio
+1.39%
Quarters Held
1
position exited
Position History RARE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2022 | 17.1K | $792,938 | +1.39% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cheyne Capital Management (UK) LLP’s full portfolio or all institutional holders of RARE.